Search research articles
Contact Us
Filters
Showing results (351-360 of 408) with videos related to
Page
of 41
Sort By:
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
The EMBO Journal
|
May 11, 2017
A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses
Marek Rajman, Franziska Metge, Roberto Fiore, et al.
The Lancet. Oncology
|
July 3, 2020
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Michael C Heinrich, Robin L Jones, Margaret von Mehren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
JAMA
|
March 29, 2012
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Cancer Medicine
|
January 18, 2019
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
Monika Scheer, Christian Vokuhl, Bernd Blank, et al.
Journal of Cancer Research and Clinical Oncology
|
January 15, 2020
Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Monika Scheer, Bernd Blank, Sebastian Bauer, et al.
Clinical Orthopaedics and Related Research
|
October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial
Dimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study
Felix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter Analysis
Theresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
Page
of 41
Search research articles
Search
Showing results (351-360 of 408) with videos related to
Sort By:
Page
of 41
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
The EMBO Journal
|
May 11, 2017
A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses
Marek Rajman, Franziska Metge, Roberto Fiore, et al.
The Lancet. Oncology
|
July 3, 2020
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Michael C Heinrich, Robin L Jones, Margaret von Mehren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
JAMA
|
March 29, 2012
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Cancer Medicine
|
January 18, 2019
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
Monika Scheer, Christian Vokuhl, Bernd Blank, et al.
Journal of Cancer Research and Clinical Oncology
|
January 15, 2020
Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Monika Scheer, Bernd Blank, Sebastian Bauer, et al.
Clinical Orthopaedics and Related Research
|
October 4, 2019
Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial
Dimosthenis Andreou, Andreas Ranft, Georg Gosheger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 19, 2012
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy--an open-label, prospective, randomised controlled multicenter study
Felix Rosenow, Carmen Schade-Brittinger, Nicole Burchardi, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter Analysis
Theresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
Page
of 41